Insider · CIK 0001170144

QUAKER BIO VENTURES LP

Reports to the SEC for 4 companies · PHILADELPHIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001170144

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-08-27	Tobira Therapeutics, Inc.C Conversion	10% Owner	CConversion	+399K sh	—	—	435,129
2013-08-27	Tobira Therapeutics, Inc.C Conversion	10% Owner	CConversion	+273K sh	—	—	708,597
2013-08-27	Tobira Therapeutics, Inc.C Conversion	10% Owner	CConversion	+465K sh	—	—	1,173,849
2013-08-27	Tobira Therapeutics, Inc.C Conversion	10% Owner	CConversion	+48.4K sh	—	—	1,222,211
2013-08-27	Tobira Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+71.8K sh	$4.00	+$287K	1,294,021
2013-08-27	Tobira Therapeutics, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−6.67M sh	—	—	0
2013-08-27	Tobira Therapeutics, Inc.Series C Preferred StockC Conversion	10% Owner	CConversion	−4.57M sh	—	—	0
2013-08-27	Tobira Therapeutics, Inc.Series D Preferred StockC Conversion	10% Owner	CConversion	−7.77M sh	—	—	0
2013-08-27	Tobira Therapeutics, Inc.Series E Preferred StockC Conversion	10% Owner	CConversion	−808K sh	—	—	0
2013-04-29	Celator Pharmaceuticals IncJ Other	10% Owner	JOther	+49.4K sh	—	—	1,287,274
2013-04-29	Celator Pharmaceuticals IncJ Other	10% Owner	JOther	+60K sh	—	—	590,427
2013-04-29	Celator Pharmaceuticals IncWarrantJ Other	10% Owner	JOther	+30.7K sh	—	—	30,708
2013-04-29	Celator Pharmaceuticals IncWarrantJ Other	10% Owner	JOther	+35.7K sh	—	—	35,737
2011-04-06	Ocera Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.19M sh	—	—	2,189,791
2011-04-06	Ocera Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+375K sh	$4.00	+$1.5M	2,564,791
2011-04-06	Ocera Therapeutics, Inc.Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−15.3M sh	—	—	0
2007-06-05	AMICUS THERAPEUTICS, INC.C Conversion	10% Owner	CConversion	+1.06M sh	—	—	1,064,822
2007-06-05	AMICUS THERAPEUTICS, INC.C Conversion	10% Owner	CConversion	+355K sh	—	—	1,419,762
2007-06-05	AMICUS THERAPEUTICS, INC.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−397K sh	—	—	0
2007-06-05	AMICUS THERAPEUTICS, INC.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−132K sh	—	—	0
2007-06-05	AMICUS THERAPEUTICS, INC.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−397K sh	—	—	0
2007-06-05	AMICUS THERAPEUTICS, INC.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−132K sh	—	—	0
2007-06-05	AMICUS THERAPEUTICS, INC.Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−136K sh	—	—	0
2007-06-05	AMICUS THERAPEUTICS, INC.Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−45.2K sh	—	—	0
2007-06-05	AMICUS THERAPEUTICS, INC.Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−136K sh	—	—	0
2007-06-05	AMICUS THERAPEUTICS, INC.Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−45.2K sh	—	—	0

Recent filings

Accepted (ET)
Aug 294
Regado Biosciences Inc0001140361-13-034587
SEC(opens sec.gov)
Jul 314
Celator Pharmaceuticals Inc0001192482-13-000152
SEC(opens sec.gov)
Apr 64
QUAKER BIO VENTURES LP0001104659-11-018945
SEC(opens sec.gov)
Jun 74
AMICUS THERAPEUTICS INC0001209191-07-035734
SEC(opens sec.gov)

Companies

Address

2929 ARCH STREET

PHILADELPHIA, PA, 19104